Does elevated parathyroid hormone concentration predict cognitive decline in older people?

Aging Clinical and Experimental Research

Volumn 22, Issue 2, 2010, Pages 164-169

  Björkman, Mikko P ^a   Sorva, Antti J ^b   Tilvis, Reijo S ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b Helsinki City Health Center   (Finland)

Author keywords

Cognition; Elderly; Hyperparathyroidism; Renal failure

Indexed keywords

APOLIPOPROTEIN E; CALCIUM ION; CREATININE; PARATHYROID HORMONE;

AGED; ALLELE; ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEMENTIA; ELDERLY CARE; FEMALE; FOLLOW UP; GROUPS BY AGE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PARATHYROID HORMONE BLOOD LEVEL; PREDICTIVE VALIDITY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RISK ASSESSMENT;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEINS E; CALCIUM; COGNITION DISORDERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FUNCTION TESTS; MALE; NEUROPSYCHOLOGICAL TESTS; PARATHYROID HORMONE; PREDICTIVE VALUE OF TESTS; TIME FACTORS; VITAMIN D DEFICIENCY;

EID: 77953105864     PISSN: 15940667     EISSN: 17208319     Source Type: Journal    
DOI: 10.1007/bf03324791     Document Type: Article

References (31)

1. Sitzer DI, Twamley EW, Jeste DV. Cognitive training in Alzheimer's disease: a meta-analysis of the literature. Acta Psychiatr Scand 2006; 114: 75-90.
2. McGuinness B, Todd S, Passmore P, Bullock R. The effects of blood pressure lowering on development of cognitive impairment and dementia in patients without apparent prior cerebrovascular disease. Cochrane Database Syst Rev 2006 Apr 19; (2): CD004034.
3. Mariani E, Monastero R, Mecocci P. Mild cognitive impairment: a systematic review. J Alzheimers Dis 2007; 12: 23-35. (Pubitemid 47396302)
4. Peters R, Beckett N, Forette F et al. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial. Lancet Neurol 2008; 7: 683-689
5. Saddichha S, Pandey V. Alzheimer's and non-Alzheimer's dementia: a critical review of pharmacological and nonpharmacological strategies. Am J Alzheimers Dis Other Demen 2008; 23: 150-161
6. Myers JS. Factors associated with changing cognitive function in older adults: implications for nursing rehabilitation. Rehabil Nurs 2008; 33: 117-123
7. Murray AM. Cognitive impairment in the aging dialysis and chronic kidney disease populations: an occult burden. Adv Chronic Kidney Dis 2008; 15: 123-132
8. Mosekilde L. Vitamin D and the elderly. Clin Endocrinol (Oxf) 2005; 62: 265-281
9. Sorva A, Valvanne J, Tilvis RS. Serum ionized calcium and the prevalence of primary hyperparathyroidism in age cohorts of 75, 80 and 85 years. J Intern Med 1992; 231: 309-312
10. Akerström G, Hellman P. Primary hyperparathyroidism. Curr Opin Oncol 2004; 16: 1-7.
11. Suliburk JW, Perrier ND. Primary hyperparathyroidism. Oncologist 2007; 12: 644-653
12. Jorde R, Waterloo K, Saleh F, Haug E, Svartberg J. Neuropsychological function in relation to serum parathyroid hormone and serum 25-hydroxyvitamin D levels. The Tromsø study. J Neurol 2006; 253: 464-470
13. Burney RE, Jones KR, Christy B, Thompson NW. Health status improvement after surgical correction of primary hyperparathyroidism in patients with high and low preoperative calcium levels. Surgery 1999; 125: 608-614
14. Chou FF, Chen JB, Hsieh KC, Liou CW. Cognitive changes after parathyroidectomy in patients with secondary hyperparathyroidism. Surgery 2008; 143: 526-532
15. Wilkins CH, Sheline YI, Roe CM, Birge SJ, Morris JC. Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am J Geriatr Psychiatry 2006; 14: 1032-1040
16. Przybelski RJ, Binkley NC. Is vitamin D important for preserving cognition? A positive correlation of serum 25-hydroxyvitarnin D concentration with cognitive function. Arch Biochem Biophys 2007; 460: 202-205
17. Oudshoom C, Mattace-Raso FU, van der Velde N, Colin EM, van der Cammen TJ. Higher serum vitamin D3 levels are associated with better cognitive test performance in patients with Alzheimer's disease. Dement Geriatr Cogn Disord 2008; 25: 539-543
18. McCann JC, Ames BN. Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction? FASEB J 2008; 22: 982-1001.
19. Tilvis RS, Kahonen-Vare MH, Jolkkonen J, Valvanne J, Pitkala KH, Strandberg TE. Predictors of cognitive decline and mortality of aged people over a 10-year period. J Gerontol Biol Med Sci 2004; 59: 268-274 (Pubitemid 38375341)
20. Ratcliffe WA, Heath DA, Ryan M, Jones SR. Performance and diagnostic application of a two-site immunoradiometric assay for parathyrin in serum. Clin Chem 1989; 35: 1957-1961 (Pubitemid 19242240)
21. Gindler EM, King JFD. Rapid colorimetric determination of calcium in biological fluids with methylthymol blue. Am J Clin Pathol 1972; 58: 376-382
22. Siggaard-Anderssen O, Thode J, Wandrup J. The concentration of free calcium ions in the blood plasma: "ionized calcium". In Siggaard-Andersen O, ed. Blood pH, Carbon Dioxide, Oxygen and Calcium-Ion. Copenhagen: Private Press, 1981: 163-190
23. Ehnholm C, Lukka M, Kuusi T, Nikkilä E, Utermann G. Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. J Lipid Res 1986; 27: 227-235 (Pubitemid 16097321)
24. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state", a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198
25. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for staging of dementia. Br J Psychiatry 1982; 140: 566-572 (Pubitemid 12124384)
26. Levey AS, Coresh J, Balk E et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137-147
27. Akmal M, Tuma S, Goldstein DA et al. Intact and carboxyterminal PTH do not cross the blood-cerebrospinal fluid barrier. Proc Soc Exp Biol Med 1984; 176: 434-437 (Pubitemid 15200347)
28. Jobom C, Hetta J, Niklasson F et al. Cerebrospinal fluid calcium, parathyroid hormone, and monoamine and purine metabolites and the blood-brain barrier function in primary hyperparathyroidism. Psychoneuroendocrinology 1991; 16: 311-322
29. Hirasawa T, Nakamura T, Mizushima A et al. Adverse effects of an active fragment of parathyroid hormone on rat hippocampal organotypic cultures. Br J Pharmacol 2000; 129: 21-28 (Pubitemid 30072667)
30. Thibault O, Gant JC, Landfield PW. Expansion of the calcium hypothesis of brain aging and Alzheimer's disease: minding the store. Aging Cell 2007; 6: 307-317
31. Björkman M, Sorva A, Tilvis R. Elevated serum parathyroid hormone predicts impaired survival prognosis in a general aged population. Eur J Endocrinol 2008; 158: 749-753